Skip to Main Content

WASHINGTON — Texas oncologist Dr. Stephen Hahn met with President Trump Wednesday about a potential nomination to helm the Food and Drug Administration, according to two Republican policy experts and one without a party affiliation.

Hahn is chief medical executive at the MD Anderson Cancer Center, but unlike many of the other men and women who have recently led the FDA, he has no Washington experience.


The meeting comes as the Trump administration is staring down an impending Nov. 1 deadline for choosing a permanent FDA commissioner. Acting Commissioner Ned Sharpless, a former director of the National Cancer Institute, is also in the running, the three experts said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!